Dr. L. Miguel Martins
Department of Molecular and Cell Biology
University of Leicester
PhD 1999 University of Porto, Portugal Postdoctoral work at the Imperial Cancer Research Fund (now known as Cancer Research UK) in London, UK Head of MRC laboratory since 2003.
To understand how intracellular signal transduction pathways modulate mitochondrial function and apoptosis.
Lehmann S, Costa AC, Celardo I, Loh SHY, Martins LM (2016) Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease. CELL DEATH & DISEASE, 7.